Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-50,850
Closed -$2.04M 1002
2022
Q2
$2.04M Hold
50,850
0.01% 798
2022
Q1
$2.44M Hold
50,850
0.01% 750
2021
Q4
$2.85M Sell
50,850
-3,725
-7% -$204K 0.01% 709
2021
Q3
$2.53M Buy
54,575
+11,773
+28% +$565K 0.01% 722
2021
Q2
$2.1M Hold
42,802
0.01% 753
2021
Q1
$2.02M Hold
42,802
0.01% 696
2020
Q4
$1.72M Buy
42,802
+12,722
+42% +$448K 0.01% 714
2020
Q3
$796K Hold
30,080
﹤0.01% 862
2020
Q2
$789K Hold
30,080
﹤0.01% 894
2020
Q1
$571K Buy
30,080
+9,530
+46% +$267K ﹤0.01% 884
2019
Q4
$756K Hold
20,550
﹤0.01% 907
2019
Q3
$671K Hold
20,550
﹤0.01% 748
2019
Q2
$645K Buy
+20,550
New +$576K ﹤0.01% 761

Other funds holding AVNT

Aviva's AVNT Position: Q3 2022 in Review

Aviva sold out of Avient (AVNT) in Q3 2022, closing a stake of 50,850 shares — an estimated $2.04M sold.

Aviva first reported a position in AVNT in Q2 2019 and held it in 13 quarters. The position peaked at $2.85M in Q4 2021. 280 funds tracked by Wall St. Rank hold AVNT as of Q3 2022.

  • Aviva reported no remaining Avient position as of Q3 2022 after selling out during the quarter.
  • Aviva sold 50,850 Avient shares in Q3 2022, an estimated $2.04M.
  • Aviva first reported a position in Avient in Q2 2019 and held it in 13 quarters.
  • Aviva's Avient position peaked at $2.85M in Q4 2021.
  • 280 funds tracked by Wall St. Rank held Avient as of Q3 2022.

Based on Aviva's 13F filing for Q3 2022, filed 14 Nov 2022.